GANAB and myeloid sarcoma: Furthermore, the Spearman rank test evidenced significant inverse correlations between GANAB and IFI35 not only in the entire study cohort of MS patients (r = −0.6468, p < 0.0001) (Figure 10) but also in the IFN-treated group (r = −0.5608, p = 0.0019) (Figure 11).